Response to 'Eruptive keratoacanthomas associated with dupilumab therapy'

Skin Health Dis. 2023 Mar 2;3(3):e197. doi: 10.1002/ski2.197. eCollection 2023 Jun.

Abstract

Case of a patient developing multiple rashes of squamous cell carcinoma 6 weeks after the introduction of dupilumab due to atopic eczema.